...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9).
【24h】

Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9).

机译:类风湿因子干扰碳水化合物抗原19-9(CA 19-9)的测定。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Investigation of a 61-year-old Caucasian male suffering from fatigue and weight loss led to the finding of a carbohydrate antigen 19-9 (CA 19-9) concentration of 80 kU/L using an ADVIA Centaur analyser. Determination of CA 19-9 on Vidas, AxSYM and Architect i2000 systems gave normal results. His rheumatoid factor concentration was very high (900 kIU/L) and assay interference was suspected. METHODS: Besides using several laboratory procedures to show the cause of the interference, we tried to estimate the frequency of the suspected interference. Therefore, two studies were performed. The first was carried out in a multicentre setting using four different CA 19-9 methods on 51 randomly selected samples with high rheumatoid factor concentrations and ten samples containing no or very low rheumatoid factor. In the second study we used heterophilic blocking tubes for 68 routinely analysed samples with CA 19-9 concentrations ranging between 37 and 250 kU/L using an ADVIA Centaur analyser. RESULTS:In the multicentre study we found eight discrepant CA 19-9 results, but only one was clearly due to interference. We showed that the interference detected, just as in the index case, was caused by rheumatoid factor. The other discrepancies could not be explained, but are probably related to method-dependent differences. In the 68 routinely analysed samples, no interference could be shown using the heterophilic blocking tubes. CONCLUSIONS: Although interferences in the CA 19-9 assay are not frequent, the ADVIA Centaur system appears to be more sensitive to rheumatoid factor interference. The lack of standardisation remains an important issue for this assay. The determination of CA 19-9 during the follow-up of patients should be performed using a single method. If, however, there is any clinical doubt about a result, CA 19-9 should be determined using another method to exclude possible interferences.
机译:背景:使用ADVIA Centaur分析仪对一名61岁的白种男性疲劳和体重减轻进行调查,结果发现其碳水化合物抗原19-9(CA 19-9)的浓度为80 kU / L。在Vidas,AxSYM和Architect i2000系统上测定CA 19-9可获得正常结果。他的类风湿因子浓度很高(900 kIU / L),怀疑存在分析干扰。方法:除了使用几种实验室程序来显示干扰的原因,我们还尝试估计可疑干扰的频率。因此,进行了两项研究。第一种是在多中心环境中使用四种不同的CA 19-9方法,对51个具有高类风湿因子浓度的随机选择的样品和十个不含或非常低类风湿因子的样品进行的。在第二项研究中,我们使用ADVIA Centaur分析仪对68个常规分析样品进行了嗜异性封闭管分析,这些样品的CA 19-9浓度在37至250 kU / L之间。结果:在多中心研究中,我们发现了8个不一致的CA 19-9结果,但只有一个明显是由于干扰。我们表明,与索引情况一样,检测到的干扰是由类风湿因子引起的。其他差异无法解释,但可能与方法相关的差异有关。在68个常规分析的样品中,使用嗜异性阻断管无法显示干扰。结论:尽管在CA 19-9分析中的干扰并不常见,但ADVIA Centaur系统似乎对类风湿因子干扰更为敏感。缺乏标准化仍然是该测定的重要问题。在患者随访期间,CA 19-9的测定应使用单一方法进行。但是,如果对结果有任何临床怀疑,则应使用另一种方法确定CA 19-9,以排除可能的干扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号